44 results
424B5
MIRM
Mirum Pharmaceuticals, Inc.
2 Nov 23
Prospectus supplement for primary offering
4:59pm
coronavirus, or together with its variants, the COVID-19 pandemic, including political or social movements arising in relation to the COVID-19 pandemic on our
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals, Inc.
2 Nov 23
Results of Operations and Financial Condition
4:06pm
and uncertainties, which include, without limitation, risks and uncertainties associated with Mirum’s business in general, the impact of the COVID-19 pandemic
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals, Inc.
13 Oct 23
Other Events
4:16pm
, including recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures, the COVID-19 pandemic and military … , the ongoing conflicts between Ukraine and Russia and Israel and Gaza, the COVID-19 pandemic, actions taken to slow its spread, actual and anticipated changes
8-K
EX-2.1
c6ezkb1
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
6vju5h2s jb3e
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
EX-99.1
mc5h3ykmqjd7716sr
9 Nov 22
Results of Operations and Financial Condition
7:30am
S-3ASR
f65v5dw msqw
9 Sep 22
Automatic shelf registration
4:31pm
424B5
8kyfjp2eubn4fxnedy1x
10 Aug 22
Prospectus supplement for primary offering
5:07pm
8-K
iw3xzb
10 Aug 22
Other Events
12:00am
424B5
uh2bm1nwlc tz9er
9 Aug 22
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
lr0z9 ct6nkcutyji
4 Aug 22
Results of Operations and Financial Condition
4:03pm
8-K
EX-99.1
3pwip9 sfwffbrcw8xb5
6 Jun 22
Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors
8:32am
8-K
EX-99.1
8ru5iweu6g a0
5 May 22
Results of Operations and Financial Condition
8:05am